Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linda T Vahdat

Showing results (1-10 of 68) with videos related to

Pageof 7
Sort By:
Cancers|November 28, 2013
Novel combinations for the treatment of metastatic breast cancerLinda T Vahdat
Seminars in Oncology|May 3, 2008
Clinical studies with epothilones for the treatment of metastatic breast cancerLinda T Vahdat
Clinical Advances in Hematology & Oncology : H&O|March 19, 2014
Novel data in metastatic breast cancerLinda T Vahdat
Oncology (Williston Park, N.Y.)|May 14, 2008
Epothilones: clinical update and future directionsDiana Donovan, Linda T Vahdat
Expert Opinion on Biological Therapy|May 16, 2017
Sacituzumab govitecan: an antibody-drug conjugateSheena Sahota, Linda T Vahdat
Expert Opinion on Pharmacotherapy|May 11, 2010
Eribulin mesylate for the treatment of breast cancerTessa Cigler, Linda T Vahdat
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2011
Eribulin mesylateSarika Jain, Linda T Vahdat
Expert Opinion on Biological Therapy|January 11, 2012
The use of an antibody drug conjugate, glembatumumab vedotin (CDX-011), for the treatment of breast cancerChristopher H Keir, Linda T Vahdat
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 20, 2004
Chemotherapy-induced peripheral neuropathy: pathogenesis and emerging therapiesAllyson J Ocean, Linda T Vahdat
Supportive Cancer Therapy|July 17, 2008
Chemotherapy-induced palmar-plantar erythrodysesthesia syndrome: etiology and emerging therapiesAmy S Clark, Linda T Vahdat
Pageof 7

Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
Cancers|November 28, 2013
Novel combinations for the treatment of metastatic breast cancerLinda T Vahdat
Seminars in Oncology|May 3, 2008
Clinical studies with epothilones for the treatment of metastatic breast cancerLinda T Vahdat
Clinical Advances in Hematology & Oncology : H&O|March 19, 2014
Novel data in metastatic breast cancerLinda T Vahdat
Oncology (Williston Park, N.Y.)|May 14, 2008
Epothilones: clinical update and future directionsDiana Donovan, Linda T Vahdat
Expert Opinion on Biological Therapy|May 16, 2017
Sacituzumab govitecan: an antibody-drug conjugateSheena Sahota, Linda T Vahdat
Expert Opinion on Pharmacotherapy|May 11, 2010
Eribulin mesylate for the treatment of breast cancerTessa Cigler, Linda T Vahdat
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2011
Eribulin mesylateSarika Jain, Linda T Vahdat
Expert Opinion on Biological Therapy|January 11, 2012
The use of an antibody drug conjugate, glembatumumab vedotin (CDX-011), for the treatment of breast cancerChristopher H Keir, Linda T Vahdat
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 20, 2004
Chemotherapy-induced peripheral neuropathy: pathogenesis and emerging therapiesAllyson J Ocean, Linda T Vahdat
Supportive Cancer Therapy|July 17, 2008
Chemotherapy-induced palmar-plantar erythrodysesthesia syndrome: etiology and emerging therapiesAmy S Clark, Linda T Vahdat
Pageof 7